Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Sanofi US
Names of Lobbyists
Firm Hired Amount Sanofi-Aventis $7,900,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Medical Research & Clin Labs,
- Economics & Econ Development,
- Fed Budget & Appropriations,
Most Frequently Disclosed Bills
Bill No. Title H.RES.295 Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease. H.R.942 American Research and Competitiveness Act of 2011 S.1884 School Access to Emergency Epinephrine Act H.R.3627 School Access to Emergency Epinephrine Act S.1577 Greater Research Opportunities With Tax Help Act H.R.5910 Global Investment in American Jobs Act of 2012 S.27 Preserve Access to Affordable Generics Act S.3274 Global Investment in American Jobs Act of 2012 S.3187 Food and Drug Administration Safety and Innovation Act S.RES.243 A resolution promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.